What is MoonLake Immunotherapeutics (MLTX) stock price today?

MoonLake Immunotherapeutics (MLTX) currently trades at $16.38 per share. The stock has a market capitalization of $1.23B and a P/E ratio of —x.

Is MLTX stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, MoonLake Immunotherapeutics has a Smart Value Score of 26/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

MLTX

MoonLake Immunotherapeutics

NASDAQ: MLTX · HEALTHCARE · BIOTECHNOLOGY

$16.38

+1.68% today

Updated 2026-04-30

Market cap

$1.23B

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-3.53

Dividend yield

—

52W range

$6 – $63

Volume

1.1M

Market cap

$1.23B

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-3.53

Dividend yield

—

52W range

$6 – $63

Volume

1.1M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

5.0

Quality

C+

3.0

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →201 stocks currently score above 75

Price targets

Analyst target

$26.71

+63.06%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

1 Strong Buy11 Buy2 Hold2 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-58.79M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-64.51M	$-36.01M	$-118.94M	$-227.32M	$-62.43M
EPS	—	—	—	—	$-3.53
Free cash flow	$-55.91M	$-43.06M	$-117.11M	$-196.04M	$-58.79M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
MLTX	$1.23B	26	4.3	3.0	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

MoonLake Immunotherapeutics trades at $16.38. Our Smart Value Score of 26/100 indicates the stock is weak.

Frequently asked questions

What is MoonLake Immunotherapeutics's stock price?

MoonLake Immunotherapeutics (MLTX) trades at $16.38.

Is MoonLake Immunotherapeutics overvalued?

Smart Value Score 26/100 (Grade F, Strong Sell).

What is the price target of MoonLake Immunotherapeutics (MLTX)?

The analyst target price is $26.71, representing +63.1% upside from the current price of $16.38.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-60.80%

Beta1.19

50D MA$17.62

200D MA$25.43

Shares out0.07B

Float0.04B

Short ratio—

Avg volume1.1M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

MLTX vs LLY →MLTX vs JNJ →MLTX vs ABBV →Stock screener →